Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis

BACKGROUND: Coronavirus disease 2019 (COVID-19) has killed over 2.5 million people worldwide, but effective care and therapy have yet to be discovered. We conducted this analysis to better understand tocilizumab treatment for COVID-19 patients. MAIN TEXT: We searched major databases for manuscripts...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Qiu, Lin, Hua, Wei, Rong-Guo, Chen, Nian, He, Fan, Zou, Dong-Hua, Wei, Jin-Ru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Scoping Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128625/
https://www.ncbi.nlm.nih.gov/pubmed/34001244
http://dx.doi.org/10.1186/s40249-021-00857-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128625/
https://www.ncbi.nlm.nih.gov/pubmed/34001244
http://dx.doi.org/10.1186/s40249-021-00857-w

Ejemplares similares